Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Pharmacological profile of lixisenatide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes
E.SouzaH
to topclose Video Americas Newsroom CLIP Fox News senior medical analyst Dr
Despite increased GLP-1 levels and incretin receptor expression on beta cells, the lower glucose levels achieved with metformin treatment were not associated with increased insulin levels [10]
Systems-wide metabolic pathway engineering in Corynebacterium glutamicum for bio-based production of diaminopentane
Download the FREE Boston 25 News app for breaking news alerts
US$ 23.42
US$ 29.81
US$ 26.54
US$ 20.41
US$ 21.92
